Jun Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jun Ma has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
Duomao Lin
Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
10 shared publicationsDongni Zhang
Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University, China
7 shared publicationsBoqun Cui
Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
6 shared publicationsZhaoqi Wang
Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China
5 shared publicationsJunwei Gao
Center for Anesthesiology, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China
4 shared publicationsYang Bai
Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Anesthesiol, Beijing, Peoples R China
4 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by IMR Press in The Heart Surgery Forum
- Vol. 29 (9)
Predictors of Physical Restraint After Cardiac Surgery: A Retrospective Cohort Study
Background: This retrospective cohort study aimed to estimate the incidence of physical restraint (PR) among patients undergoing elective cardiac surgery, characterize the associated clinical features, and identify independent predictors of PR after transfer to the general ward. Methods: We analyzed data from 3941 adult patients at Beijing Anzhen (2018–2025). PR cases were identified through electronic medical records. Univariate and multivariable logistic regression analyses were performed to identify independent risk factors among perioperative variables. Model performance was evaluated using the C-statistic and the Hosmer–Lemeshow test, and internal stability was assessed via bootstrap resampling. Results: The overall incidence of PR was 5.2% (206/3941). Multivariable logistic regression identified four independent predictors: advanced age (adjusted odds ratio [aOR]: 1.04; 95% confidence interval [CI]: 1.02–1.05; p < 0.001), use of deep hypothermic circulatory arrest (DHCA) (aOR: 3.52; 95% CI: 1.90–6.51; p < 0.001), remimazolam for maintenance of anesthesia compared with propofol (aOR: 2.19; 95% CI: 1.15–4.18; p = 0.017), and prolonged length of stay in the intensive care unit (ICU) (aOR: 1.01; 95% CI: 1.01–1.01; p < 0.001). In an exploratory analysis restricted to patients aged ≥65 years, remimazolam maintenance was associated with higher odds of PR than propofol in a parsimonious Firth-penalized logistic regression model (adjusted OR, 5.29; 95% CI: 2.07–13.49; p < 0.001). Conclusions: Advanced age, DHCA procedures, remimazolam-based anesthesia, and extended ICU stays independently predict the use of PR in patients undergoing cardiac surgery. These findings may facilitate risk stratification and underscore the need for targeted perioperative interventions and careful anesthetic selection to minimize unnecessary restraint.
- 18 September 2026
- Published by IMR Press in The Heart Surgery Forum
- Vol. 29 (9)
Open AccessPredictors of Physical Restraint After Cardiac Surgery: A Retrospective Cohort Study
Background: This retrospective cohort study aimed to estimate the incidence of physical restraint (PR) among patients undergoing elective cardiac surgery, characterize the associated clinical features, and identify independent predictors of PR after transfer to the general ward. Methods: We analyzed data from 3941 adult patients at Beijing Anzhen (2018–2025). PR cases were identified through electronic medical records. Univariate and multivariable logistic regression analyses were performed to identify independent risk factors among perioperative variables. Model performance was evaluated using the C-statistic and the Hosmer–Lemeshow test, and internal stability was assessed via bootstrap resampling. Results: The overall incidence of PR was 5.2% (206/3941). Multivariable logistic regression identified four independent predictors: advanced age (adjusted odds ratio [aOR]: 1.04; 95% confidence interval [CI]: 1.02–1.05; p < 0.001), use of deep hypothermic circulatory arrest (DHCA) (aOR: 3.52; 95% CI: 1.90–6.51; p < 0.001), remimazolam for maintenance of anesthesia compared with propofol (aOR: 2.19; 95% CI: 1.15–4.18; p = 0.017), and prolonged length of stay in the intensive care unit (ICU) (aOR: 1.01; 95% CI: 1.01–1.01; p < 0.001). In an exploratory analysis restricted to patients aged ≥65 years, remimazolam maintenance was associated with higher odds of PR than propofol in a parsimonious Firth-penalized logistic regression model (adjusted OR, 5.29; 95% CI: 2.07–13.49; p < 0.001). Conclusions: Advanced age, DHCA procedures, remimazolam-based anesthesia, and extended ICU stays independently predict the use of PR in patients undergoing cardiac surgery. These findings may facilitate risk stratification and underscore the need for targeted perioperative interventions and careful anesthetic selection to minimize unnecessary restraint.
- Open Access
- 18 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2331
Intraoperative High-Volume Diuresis During Off-Pump Coronary Artery Bypass Grafting: Risk Factors and Clinical Impact
Background: Intraoperative high-volume diuresis is a common but under-recognized phenomenon during off-pump coronary artery bypass grafting (OPCABG). Its clinical correlates and implications for perioperative management remain incompletely characterized. Methods: This single-center retrospective cohort study included 1274 adults undergoing elective OPCABG between January and August 2025. High-volume diuresis was defined as urine output ≥ 5 mL·kg−1·h−1. Multivariable logistic regression was used to identify factors independently associated with intraoperative high-volume diuresis. Model discrimination was assessed using the area under the receiver operating characteristic curve (AUC). Results: High-volume diuresis occurred in 39.6% of patients. Older age, hypertension and greater intraoperative fluid infusion were independently associated with high-volume diuresis, whereas preoperative diuretic and greater cumulative exposure to systolic blood pressure < 100 mmHg were inversely associated with diuresis. The multivariable model demonstrated acceptable discrimination (AUC = 0.756). Postoperative outcomes, including acute kidney injury, duration of mechanical ventilation, intensive care unit stay, and hospital length of stay, did not differ between groups. Conclusions: Intraoperative high-volume diuresis during OPCABG reflects complex physiological and hemodynamic responses and can be anticipated based on preoperative and intraoperative factors. These findings support a more individualized interpretation of urine output and perioperative management strategies in OPCABG.
- 18 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2331
Open AccessIntraoperative High-Volume Diuresis During Off-Pump Coronary Artery Bypass Grafting: Risk Factors and Clinical Impact
Background: Intraoperative high-volume diuresis is a common but under-recognized phenomenon during off-pump coronary artery bypass grafting (OPCABG). Its clinical correlates and implications for perioperative management remain incompletely characterized. Methods: This single-center retrospective cohort study included 1274 adults undergoing elective OPCABG between January and August 2025. High-volume diuresis was defined as urine output ≥ 5 mL·kg−1·h−1. Multivariable logistic regression was used to identify factors independently associated with intraoperative high-volume diuresis. Model discrimination was assessed using the area under the receiver operating characteristic curve (AUC). Results: High-volume diuresis occurred in 39.6% of patients. Older age, hypertension and greater intraoperative fluid infusion were independently associated with high-volume diuresis, whereas preoperative diuretic and greater cumulative exposure to systolic blood pressure < 100 mmHg were inversely associated with diuresis. The multivariable model demonstrated acceptable discrimination (AUC = 0.756). Postoperative outcomes, including acute kidney injury, duration of mechanical ventilation, intensive care unit stay, and hospital length of stay, did not differ between groups. Conclusions: Intraoperative high-volume diuresis during OPCABG reflects complex physiological and hemodynamic responses and can be anticipated based on preoperative and intraoperative factors. These findings support a more individualized interpretation of urine output and perioperative management strategies in OPCABG.
- Open Access
- 26 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (23) , 8395
Hormonal and Osmoregulatory Responses in Intraoperative High-Volume Diuresis During Off-Pump Coronary Artery Bypass Grafting: An Exploratory Cohort Study
Background: Intraoperative high-volume diuresis is a frequent but underrecognized complication in cardiac surgery, potentially leading to hypovolemia, electrolyte imbalances, and hemodynamic instability. Its mechanisms remain poorly defined. This study investigated the hormonal and biochemical regulation of urine output during off-pump coronary artery bypass grafting (OPCABG). Methods: For this single-center observational cohort study, 70 patients undergoing OPCABG were enrolled (diuresis: urine output > 5 mL/kg/h, n = 38; normal, n = 32). Hormonal markers and osmolality parameters were measured perioperatively. Logistic regression was used to identify independent predictors, and receiver operating characteristic (ROC) curves was used to assess model performance. Results: Intraoperative high-volume diuresis occurred in 54.2% of patients. Logistic regression identified a low Body Mass Index (BMI) (OR 0.72, p = 0.002), reduced albumin (OR 0.75, p = 0.014), and lower copeptin (OR 0.43, p = 0.037) as independent predictors (AUC 0.855). Perioperatively, NT-proBNPT0 rose in both groups, aldosterone increased only in the diuresis group, and copeptin showed a slight nonsignificant rise. Plasma sodium was higher in cases of diuresis at the end of surgery (148.4 vs. 144.9 mmol/L, p < 0.001). Despite greater urine output and fluid infusion, the rates of intensive care unit (ICU) admission and hospital stays were similar. Conclusions: Intraoperative high-volume diuresis in OPCABG is strongly associated with reduced antidiuretic hormone activity, suggesting a partial central diabetes insipidus-like mechanism. Although not affecting short-term outcomes, it posed challenges for intraoperative fluid and electrolyte management. Larger multicenter studies are needed for validation.
- 26 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (23) , 8395
Open AccessHormonal and Osmoregulatory Responses in Intraoperative High-Volume Diuresis During Off-Pump Coronary Artery Bypass Grafting: An Exploratory Cohort Study
Background: Intraoperative high-volume diuresis is a frequent but underrecognized complication in cardiac surgery, potentially leading to hypovolemia, electrolyte imbalances, and hemodynamic instability. Its mechanisms remain poorly defined. This study investigated the hormonal and biochemical regulation of urine output during off-pump coronary artery bypass grafting (OPCABG). Methods: For this single-center observational cohort study, 70 patients undergoing OPCABG were enrolled (diuresis: urine output > 5 mL/kg/h, n = 38; normal, n = 32). Hormonal markers and osmolality parameters were measured perioperatively. Logistic regression was used to identify independent predictors, and receiver operating characteristic (ROC) curves was used to assess model performance. Results: Intraoperative high-volume diuresis occurred in 54.2% of patients. Logistic regression identified a low Body Mass Index (BMI) (OR 0.72, p = 0.002), reduced albumin (OR 0.75, p = 0.014), and lower copeptin (OR 0.43, p = 0.037) as independent predictors (AUC 0.855). Perioperatively, NT-proBNPT0 rose in both groups, aldosterone increased only in the diuresis group, and copeptin showed a slight nonsignificant rise. Plasma sodium was higher in cases of diuresis at the end of surgery (148.4 vs. 144.9 mmol/L, p < 0.001). Despite greater urine output and fluid infusion, the rates of intensive care unit (ICU) admission and hospital stays were similar. Conclusions: Intraoperative high-volume diuresis in OPCABG is strongly associated with reduced antidiuretic hormone activity, suggesting a partial central diabetes insipidus-like mechanism. Although not affecting short-term outcomes, it posed challenges for intraoperative fluid and electrolyte management. Larger multicenter studies are needed for validation.
- Open Access
- 10 September 2025
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 56 (5) , 1-12
Exercise training for myocardial ischemia reperfusion injury: Mechanism and clinical practice (Review)
Myocardial ischemia reperfusion injury (MIRI) remains a key and difficult issue in the field of cardiovascular diseases, and its pathogenesis involves multiple aspects. Exercise can effectively improve MIRI, and the mechanisms include reducing oxidative stress and inflammatory responses, regulating mitochondrial function and metabolic abnormalities, and so on. For patients undergoing reperfusion, rehabilitation therapy mainly based on exercise has important clinical significance. The present study expounded on the occurrence of MIRI from the perspective of mechanisms and the improvement effect of exercise on MIRI, elaborates on the main current exercise strategies and existing problems from the aspect of clinical practice, and discusses the possible future development directions.
- 10 September 2025
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 56 (5) , 1-12
Open AccessExercise training for myocardial ischemia reperfusion injury: Mechanism and clinical practice (Review)
Myocardial ischemia reperfusion injury (MIRI) remains a key and difficult issue in the field of cardiovascular diseases, and its pathogenesis involves multiple aspects. Exercise can effectively improve MIRI, and the mechanisms include reducing oxidative stress and inflammatory responses, regulating mitochondrial function and metabolic abnormalities, and so on. For patients undergoing reperfusion, rehabilitation therapy mainly based on exercise has important clinical significance. The present study expounded on the occurrence of MIRI from the perspective of mechanisms and the improvement effect of exercise on MIRI, elaborates on the main current exercise strategies and existing problems from the aspect of clinical practice, and discusses the possible future development directions.
- Open Access
- 1 September 2025
- Published by KEAI Publishing in Journal of Anesthesia and Translational Medicine
- Vol. 4 (3) , 142-147
Remimazolam in anesthesia and sedation: A narrative review
Remimazolam, an innovative sedative, provides a rapid onset and quick recovery by being rapidly hydrolyzed into pharmacologically inactive CNS7054 via ubiquitous nonspecific esterases. Its pharmacokinetic characteristics (high clearance rate, small steady-state volume of distribution, short terminal half-life, and no tissue accumulation) further lay the foundation for clinical application. Compared with traditional sedative drugs, the prominent innovations of this drug are reflected in three aspects: first, it has less impact on the respiratory and circulatory systems, with stable hemodynamics and a low incidence of discomfort at the administration site; second, its sedative effect can be specifically antagonized by flumazenil, allowing for more flexible safety regulation; third, it shows excellent safety and effectiveness in special populations such as elderly patients and those with comorbid cardiovascular diseases. Clinical evidence shows that remimazolam is more effective than similar drugs in scenarios such as gastrointestinal endoscopy, operating rooms, and ICUs. Its reliable performance in special populations further supports its value as a sedative that combines innovation with clinical practicality and holds broad application prospects. This review aims to systematically elaborate on the pharmacological properties and clinical application value of remimazolam, a new benzodiazepine derivative, and provide references for its standardized use in various diagnostic and therapeutic scenarios and special populations.
- 1 September 2025
- Published by KEAI Publishing in Journal of Anesthesia and Translational Medicine
- Vol. 4 (3) , 142-147
Open AccessRemimazolam in anesthesia and sedation: A narrative review
Remimazolam, an innovative sedative, provides a rapid onset and quick recovery by being rapidly hydrolyzed into pharmacologically inactive CNS7054 via ubiquitous nonspecific esterases. Its pharmacokinetic characteristics (high clearance rate, small steady-state volume of distribution, short terminal half-life, and no tissue accumulation) further lay the foundation for clinical application. Compared with traditional sedative drugs, the prominent innovations of this drug are reflected in three aspects: first, it has less impact on the respiratory and circulatory systems, with stable hemodynamics and a low incidence of discomfort at the administration site; second, its sedative effect can be specifically antagonized by flumazenil, allowing for more flexible safety regulation; third, it shows excellent safety and effectiveness in special populations such as elderly patients and those with comorbid cardiovascular diseases. Clinical evidence shows that remimazolam is more effective than similar drugs in scenarios such as gastrointestinal endoscopy, operating rooms, and ICUs. Its reliable performance in special populations further supports its value as a sedative that combines innovation with clinical practicality and holds broad application prospects. This review aims to systematically elaborate on the pharmacological properties and clinical application value of remimazolam, a new benzodiazepine derivative, and provide references for its standardized use in various diagnostic and therapeutic scenarios and special populations.
- Open Access
- 17 July 2025
- Published by Springer Nature in Cytotechnology
- Vol. 77 (4) , 150
Sevoflurane induces Ca2+ overload and EFHD1 upregulation, driving pyroptosis in SCLC cells
Sevoflurane, a widely utilized inhalational anesthetic, has been shown in previous studies to inhibit the proliferation and invasion of non-small cell lung cancer (NSCLC) cells. However, whether sevoflurane affects the metastasis of small cell lung cancer (SCLC) cells remains unexplored. This study's primary objective was to investigate the mechanism by which sevoflurane induces calcium overload and EFHD1 upregulation, thereby contributing to pyroptosis in SCLC cells. NCI-H446 cells were treated with sevoflurane at concentrations of 0%, 0.6%, 3% and 15%. Cell proliferation was assessed using the CCK8 assay, while cell migration and invasion were analyzed using the Transwell assay. EFHD1 expression was determined by q-PCR and Western blot. Calcium content, ROS levels, and CCO content were measured using respective assay kits, and mitochondrial morphology was observed using transmission electron microscopy. Western blotting was performed to detect the expression of caspase-1 and GSDMD. All procedures were repeated under conditions of EFHD1 overexpression or silencing. Sevoflurane inhibited the proliferation, migration, and invasion of NCI-H446 cells, concurrently exerting a significant pro-pyroptotic effect. This was mediated by mitochondrial calcium overload, EFHD1 upregulation, and subsequent mitochondrial damage-induced pyroptosis. Sevoflurane significantly enhances pyroptosis in NCI-H446 cells, thereby potentially reducing cancer cell dissemination during surgery.
- 17 July 2025
- Published by Springer Nature in Cytotechnology
- Vol. 77 (4) , 150
Open AccessSevoflurane induces Ca2+ overload and EFHD1 upregulation, driving pyroptosis in SCLC cells
Sevoflurane, a widely utilized inhalational anesthetic, has been shown in previous studies to inhibit the proliferation and invasion of non-small cell lung cancer (NSCLC) cells. However, whether sevoflurane affects the metastasis of small cell lung cancer (SCLC) cells remains unexplored. This study's primary objective was to investigate the mechanism by which sevoflurane induces calcium overload and EFHD1 upregulation, thereby contributing to pyroptosis in SCLC cells. NCI-H446 cells were treated with sevoflurane at concentrations of 0%, 0.6%, 3% and 15%. Cell proliferation was assessed using the CCK8 assay, while cell migration and invasion were analyzed using the Transwell assay. EFHD1 expression was determined by q-PCR and Western blot. Calcium content, ROS levels, and CCO content were measured using respective assay kits, and mitochondrial morphology was observed using transmission electron microscopy. Western blotting was performed to detect the expression of caspase-1 and GSDMD. All procedures were repeated under conditions of EFHD1 overexpression or silencing. Sevoflurane inhibited the proliferation, migration, and invasion of NCI-H446 cells, concurrently exerting a significant pro-pyroptotic effect. This was mediated by mitochondrial calcium overload, EFHD1 upregulation, and subsequent mitochondrial damage-induced pyroptosis. Sevoflurane significantly enhances pyroptosis in NCI-H446 cells, thereby potentially reducing cancer cell dissemination during surgery.
- Open Access
- 16 April 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (4) , 28279
Predictive Effect of GDF-15 on Adverse Outcomes After Cardiovascular Interventions: A Systematic Review and Meta-Analysis
Background: This systematic review and meta-analysis aimed to evaluate the predictive effect of Growth Differentiation Factor-15 (GDF-15) on adverse outcomes in patients undergoing cardiovascular interventions. Method: A comprehensive literature search was performed across PubMed, EMBASE, Cochrane Library, and Web of Science databases. The meta-analysis used hazard ratios (HR) and odds ratios (OR) to compare outcomes such as all-cause mortality, cardiovascular death, postoperative atrial fibrillation (AF), acute kidney injury (AKI), and spontaneous myocardial infarction (MI) between high GDF-15 levels and control groups. Subgroup analyses were conducted based on study design and GDF-15 cutoff levels. Publication bias was evaluated using funnel plot and Egger’s test. Results: A total of 13 studies were included in the meta-analysis. The study revealed a significant association between elevated GDF-15 levels and increased all-cause mortality. Subgroup analysis showed a significant association in retrospective studies but not in prospective studies. Higher GDF-15 cutoff levels (>2 ng/mL) were more strongly associated with increased mortality than lower cutoff levels (≤2 ng/mL). Elevated GDF-15 levels were found to be significantly associated with increased risks of cardiovascular death, AKI, and spontaneous MI. No significant difference was observed in the incidence of postoperative AF. The overall adverse outcomes analysis showed no significant difference. Subgroup analyses suggested significant associations primarily observed in studies with higher GDF-15 cutoffs. Conclusion: Elevated GDF-15 levels are associated with increased risks of all-cause mortality, cardiovascular death, AKI, and spontaneous MI in patients undergoing cardiovascular interventions. Due to the heterogeneity of the studies, including variations in surgical techniques, the conclusions should be interpreted with caution. The PROSPERO Registration: CRD42024582279, https://www.crd.york.ac.uk/PROSPERO/view/CRD42024582279.
- 16 April 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (4) , 28279
Open AccessPredictive Effect of GDF-15 on Adverse Outcomes After Cardiovascular Interventions: A Systematic Review and Meta-Analysis
Background: This systematic review and meta-analysis aimed to evaluate the predictive effect of Growth Differentiation Factor-15 (GDF-15) on adverse outcomes in patients undergoing cardiovascular interventions. Method: A comprehensive literature search was performed across PubMed, EMBASE, Cochrane Library, and Web of Science databases. The meta-analysis used hazard ratios (HR) and odds ratios (OR) to compare outcomes such as all-cause mortality, cardiovascular death, postoperative atrial fibrillation (AF), acute kidney injury (AKI), and spontaneous myocardial infarction (MI) between high GDF-15 levels and control groups. Subgroup analyses were conducted based on study design and GDF-15 cutoff levels. Publication bias was evaluated using funnel plot and Egger’s test. Results: A total of 13 studies were included in the meta-analysis. The study revealed a significant association between elevated GDF-15 levels and increased all-cause mortality. Subgroup analysis showed a significant association in retrospective studies but not in prospective studies. Higher GDF-15 cutoff levels (>2 ng/mL) were more strongly associated with increased mortality than lower cutoff levels (≤2 ng/mL). Elevated GDF-15 levels were found to be significantly associated with increased risks of cardiovascular death, AKI, and spontaneous MI. No significant difference was observed in the incidence of postoperative AF. The overall adverse outcomes analysis showed no significant difference. Subgroup analyses suggested significant associations primarily observed in studies with higher GDF-15 cutoffs. Conclusion: Elevated GDF-15 levels are associated with increased risks of all-cause mortality, cardiovascular death, AKI, and spontaneous MI in patients undergoing cardiovascular interventions. Due to the heterogeneity of the studies, including variations in surgical techniques, the conclusions should be interpreted with caution. The PROSPERO Registration: CRD42024582279, https://www.crd.york.ac.uk/PROSPERO/view/CRD42024582279.
- Open Access
- 25 February 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-15
Tumor microenvironment and drug resistance in lung adenocarcinoma: molecular mechanisms, prognostic implications, and therapeutic strategies
The fight against lung adenocarcinoma (LUAD) is challenged by tumor microenvironment (TME)-mediated drug resistance, which limits effective treatment. This study examines the LUAD TME and identifies four distinct subtypes through multi-omics profiling: immune-rich, immune-exhausted, stromal-dominant, and TME-desert. Each subtype has unique molecular features, tumor diversity, and links to clinical outcomes. Immune-rich subtypes respond better to immune checkpoint inhibitors, while stromal-dominant and TME-desert subtypes show resistance to treatment and poor prognosis. Molecular analysis uncovers subtype-specific mutations, chromosomal instability, and altered signaling pathways, pointing to potential therapeutic targets. In silico drug screening identifies promising treatments for resistant subtypes. These findings, validated in independent cohorts, highlight the critical role of the TME in drug resistance and treatment response, providing insights for personalized treatment strategies in LUAD.
- 25 February 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-15
Open AccessTumor microenvironment and drug resistance in lung adenocarcinoma: molecular mechanisms, prognostic implications, and therapeutic strategies
The fight against lung adenocarcinoma (LUAD) is challenged by tumor microenvironment (TME)-mediated drug resistance, which limits effective treatment. This study examines the LUAD TME and identifies four distinct subtypes through multi-omics profiling: immune-rich, immune-exhausted, stromal-dominant, and TME-desert. Each subtype has unique molecular features, tumor diversity, and links to clinical outcomes. Immune-rich subtypes respond better to immune checkpoint inhibitors, while stromal-dominant and TME-desert subtypes show resistance to treatment and poor prognosis. Molecular analysis uncovers subtype-specific mutations, chromosomal instability, and altered signaling pathways, pointing to potential therapeutic targets. In silico drug screening identifies promising treatments for resistant subtypes. These findings, validated in independent cohorts, highlight the critical role of the TME in drug resistance and treatment response, providing insights for personalized treatment strategies in LUAD.
- Open Access
- 31 January 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1528147
Development and validation of a prediction model for acute kidney injury following cardiac valve surgery
Background: Acute kidney injury (AKI) often accompanies cardiac valve surgery, and worsens patient outcome. The aim of our study is to identify preoperative and intraoperative independent risk factors for AKI in patients undergoing cardiac valve surgery. Using these factors, we developed a risk prediction model for AKI after cardiac valve surgery and conducted external validation.Methods: Our retrospective study recruited 497 adult patients undergoing cardiac valve surgery as a derivation cohort between February and August 2023. Patient demographics, including medical history and perioperative clinical information, were acquired, and patients were classified into one of two cohorts, AKI and non-AKI, according to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. Using binary logistic stepwise regression analysis, we identified independent AKI risk factors after cardiac valve surgery. Lastly, we constructed a nomogram and conducted external validation in a validation cohort comprising 200 patients. The performance of the nomogram was evaluated based on the area under the receiver operating characteristic curve (AUC), calibration curves and decision curve analysis (DCA).Results: In the derivation cohort, 172 developed AKI (34.6%). Relative to non-AKI patients, the AKI patients exhibited elevated postoperative complication incidences and worse outcome. Based on multivariate analysis, advanced age (OR: 1.855; p = 0.011), preoperative hypertension (OR: 1.91; p = 0.017), coronary heart disease (OR: 6.773; p < 0.001), preoperative albumin (OR: 0.924; p = 0.015), D-Dimer (OR: 1.001; p = 0.038), plasma creatinine (OR: 1.025; p = 0.001), cardiopulmonary bypass (CPB) duration (OR: 1.011; p = 0.001), repeat CPB (OR: 6.195; p = 0.010), intraoperative red blood cell transfusion (OR: 2.560; p < 0.001), urine volume (OR: 0.406 p < 0.001) and vasoactive–inotropic score (OR: 1.135; p = 0.009) were independent risk factors for AKI. The AUC of the nomogram in the derivation and validation cohorts were 0.814 (95%CI: 0.775–0.854) and 0.798 (95%CI: 0.726–0.871), respectively. Furthermore, the calibration curve revealed that the predicted outcome was in agreement with the actual observations. Finally, the DCA curves showed that the nomogram had a good clinical applicability value.Conclusion: Several perioperative factors modulate AKI development following cardiac valve surgery, resulting in poor patient prognosis. The proposed AKI predictive model is both sensitive and precise, and can assist in high-risk patient screening in the clinics.
- 31 January 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1528147
Open AccessDevelopment and validation of a prediction model for acute kidney injury following cardiac valve surgery
Background: Acute kidney injury (AKI) often accompanies cardiac valve surgery, and worsens patient outcome. The aim of our study is to identify preoperative and intraoperative independent risk factors for AKI in patients undergoing cardiac valve surgery. Using these factors, we developed a risk prediction model for AKI after cardiac valve surgery and conducted external validation.Methods: Our retrospective study recruited 497 adult patients undergoing cardiac valve surgery as a derivation cohort between February and August 2023. Patient demographics, including medical history and perioperative clinical information, were acquired, and patients were classified into one of two cohorts, AKI and non-AKI, according to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines. Using binary logistic stepwise regression analysis, we identified independent AKI risk factors after cardiac valve surgery. Lastly, we constructed a nomogram and conducted external validation in a validation cohort comprising 200 patients. The performance of the nomogram was evaluated based on the area under the receiver operating characteristic curve (AUC), calibration curves and decision curve analysis (DCA).Results: In the derivation cohort, 172 developed AKI (34.6%). Relative to non-AKI patients, the AKI patients exhibited elevated postoperative complication incidences and worse outcome. Based on multivariate analysis, advanced age (OR: 1.855; p = 0.011), preoperative hypertension (OR: 1.91; p = 0.017), coronary heart disease (OR: 6.773; p < 0.001), preoperative albumin (OR: 0.924; p = 0.015), D-Dimer (OR: 1.001; p = 0.038), plasma creatinine (OR: 1.025; p = 0.001), cardiopulmonary bypass (CPB) duration (OR: 1.011; p = 0.001), repeat CPB (OR: 6.195; p = 0.010), intraoperative red blood cell transfusion (OR: 2.560; p < 0.001), urine volume (OR: 0.406 p < 0.001) and vasoactive–inotropic score (OR: 1.135; p = 0.009) were independent risk factors for AKI. The AUC of the nomogram in the derivation and validation cohorts were 0.814 (95%CI: 0.775–0.854) and 0.798 (95%CI: 0.726–0.871), respectively. Furthermore, the calibration curve revealed that the predicted outcome was in agreement with the actual observations. Finally, the DCA curves showed that the nomogram had a good clinical applicability value.Conclusion: Several perioperative factors modulate AKI development following cardiac valve surgery, resulting in poor patient prognosis. The proposed AKI predictive model is both sensitive and precise, and can assist in high-risk patient screening in the clinics.
- 8 January 2025
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 39 (4) , 1026-1036
Advances in Anesthesia Techniques for Postoperative Pain Management in Minimally Invasive Cardiac Surgery: An Expert Opinion
- 8 January 2025
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 39 (4) , 1026-1036
Advances in Anesthesia Techniques for Postoperative Pain Management in Minimally Invasive Cardiac Surgery: An Expert Opinion